uridine has been researched along with HIV-Associated Lipodystrophy Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McComsey, G; Tungsiripat, M | 1 |
| Bloch, M; Calmy, A; Carr, A; Cooper, DA; Delhumeau, C; Finlayson, R; Hirschel, B; Norris, R; Rafferty, M; Wand, H | 1 |
| Aberg, JA; Budhathoki, CB; Charles, S; Currier, JS; Kosmiski, L; McComsey, GA; Medvik, K; Naini, LG; Su, Z; Walker, UA | 1 |
| Andreu, A; Cano-Soldado, P; Domingo, JC; Domingo, P; Fernandez, I; Gallego-Escuredo, JM; Giralt, M; Gutierrez, Mdel M; Marti, R; Mateo, MG; Pastor-Anglada, M; Pomar, V; Torres-Torronteras, J; Vidal, F; Villarroya, F | 1 |
| Choi, J; Gerschenson, M; Harrill, D; Libutti, D; McComsey, GA; O'Riordan, M; Rowe, D; Storer, N | 1 |
| Banasch, M; Brockmeyer, NH; Bulut, K; Goetze, O; Knyhala, K; Kwiatek, MA; Potthoff, A; Schlottmann, R; Schmidt, WE; Schmitz, F | 1 |
| Häkkinen, AM; Klinker, H; Ristola, M; Sevastianova, K; Sutinen, J; Walker, UA; Yki-Järvinen, H | 1 |
| Baron, E; Lebrecht, D; McComsey, GA; O'Riordan, M; Setzer, B; Walker, UA | 1 |
1 review(s) available for uridine and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Pathogenesis and management of lipoatrophy.
Topics: Adipose Tissue; Anti-HIV Agents; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Thiazolidinediones; Uridine | 2008 |
5 trial(s) available for uridine and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
No significant effect of uridine or pravastatin treatment for HIV lipoatrophy in men who have ceased thymidine analogue nucleoside reverse transcriptase inhibitor therapy: a randomized trial.
Topics: Absorptiometry, Photon; Adiposity; Adult; Anti-Retroviral Agents; Anticholesteremic Agents; Dideoxynucleosides; Drug Therapy, Combination; Extremities; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Lopinavir; Male; Middle Aged; Pravastatin; Pyrimidinones; Reverse Transcriptase Inhibitors; Ritonavir; Uridine | 2010 |
Uridine supplementation in the treatment of HIV lipoatrophy: results of ACTG 5229.
Topics: Adult; CD4 Lymphocyte Count; Double-Blind Method; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Medication Adherence; Pilot Projects; Quality of Life; Uridine; Viral Load | 2010 |
Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir.
Topics: Adenine; Adipocytes; Adipose Tissue; Adult; Anti-HIV Agents; Apoptosis; Bone Density; DNA, Mitochondrial; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Inflammation; Male; Middle Aged; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; RNA; RNA, Mitochondrial; Tenofovir; Uridine; Viral Load | 2012 |
Uridine supplementation enhances hepatic mitochondrial function in thymidine-analogue treated HIV-infected patients.
Topics: Anti-HIV Agents; Breath Tests; Dietary Supplements; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Mitochondria, Liver; Reverse Transcriptase Inhibitors; Uridine | 2006 |
Uridine supplementation for the treatment of antiretroviral therapy-associated lipoatrophy: a randomized, double-blind, placebo-controlled trial.
Topics: Absorptiometry, Photon; Administration, Oral; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Fat Distribution; Dietary Supplements; Double-Blind Method; Drug Administration Schedule; Female; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Spectrum Analysis; Subcutaneous Fat; Treatment Outcome; Uridine | 2007 |
2 other study(ies) available for uridine and HIV-Associated Lipodystrophy Syndrome
| Article | Year |
|---|---|
Uridine metabolism in HIV-1-infected patients: effect of infection, of antiretroviral therapy and of HIV-1/ART-associated lipodystrophy syndrome.
Topics: Adipose Tissue; Adult; Antiretroviral Therapy, Highly Active; Female; Gene Expression; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Lipids; Male; Middle Aged; Nucleoside Transport Proteins; Reverse Transcriptase Polymerase Chain Reaction; Uridine; Uridine Kinase; Uridine Phosphorylase | 2010 |
Uridine supplementation in HIV lipoatrophy: pilot trial on safety and effect on mitochondrial indices.
Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Body Composition; Body Fat Distribution; Dietary Supplements; DNA, Mitochondrial; Female; HIV Infections; HIV-Associated Lipodystrophy Syndrome; Humans; Male; Middle Aged; Pilot Projects; Safety; Subcutaneous Fat; Treatment Outcome; Uridine | 2008 |